Jean‐Yves Reginster

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

Michael R. McClung, Andreas Grauer, Steven Boonen et al. · New England Journal of Medicine · 2014 · 1.2K citations

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi et al. · The Lancet Diabetes & Endocrinology · 2017 · 916 citations · Full text

Bone Disease, Denosumab Treatment, Bone Health +9

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

Jean‐Yves Reginster, J Badurski, Nicholas Bellamy et al. · Annals of the Rheumatic Diseases · 2012 · 286 citations · Full text

Long‐term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: The study on osteoarthritis progression prevention, a two‐year, randomized, double‐blind, placebo‐controlled trial

André Kahan, Daniel Uebelhart, Florent de Vathaire et al. · Arthritis & Rheumatism · 2009 · 265 citations

Effects of long‐term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five‐year, randomized, placebo‐controlled trial

Jean‐Yves Reginster, Dieter Felsenberg, Steven Boonen et al. · Arthritis & Rheumatism · 2008 · 262 citations · Full text